Imaging is the common thread across EXIST (Extended Image Sensing Technologies), ASTONISH (Smart Optical Imaging) and PHOOTONICS (hyperspectral imaging for diabetic foot monitoring).
QUEST INNOVATIONS BV
Dutch SME building hyperspectral NIR and mid-IR imaging hardware, moving from ECSEL electronic components into photonic devices for medical diagnostics.
Their core work
Quest Innovations is a Dutch technology SME that designs and builds advanced image sensing systems, with deep expertise in multispectral and hyperspectral camera technology. Their engineering centres on capturing light beyond the visible range — near-infrared (NIR) and mid-infrared (mid-IR) — using custom photodetectors and active illumination modules. They work as a specialist technology supplier inside larger electronics and photonics consortia, translating sensor science into deployable imaging hardware for industrial and, increasingly, medical use cases.
What they specialise in
PHOOTONICS explicitly lists passive photodetectors, active illuminators, NIR and mid-IR sensing as their contribution to the device.
ASTONISH (Smart Optical Imaging and Sensing for Health) and PHOOTONICS (diabetic foot prediction and monitoring) move their imaging work into medical devices.
Both EXIST and ASTONISH were funded under ECSEL-RIA, the EU public-private partnership for electronic components and systems integration.
PHOOTONICS (2019-2024) marks their shift toward cost-effective photonic devices for clinical prediction and monitoring.
How they've shifted over time
In 2015-2018 their work (EXIST, ASTONISH) sat inside the ECSEL electronic components programme, developing generic extended image sensing building blocks and early smart optical sensing for health. From 2019 onward (PHOOTONICS) the focus sharpens dramatically: from generic sensor IP toward a concrete hyperspectral NIR/mid-IR device aimed at diabetic foot ulcer prediction. The trajectory is a classic SME maturation — moving from component R&D into vertical, clinically targeted photonic products.
They are moving from being a generic imaging-technology supplier toward a photonics device maker for medical diagnostics, making them an attractive partner for health-tech and medtech consortia.
How they like to work
Quest Innovations has participated exclusively as a third party in all three of their H2020 projects — a linked or subcontracted specialist rather than a lead beneficiary. They work inside large, multi-country consortia (49 partners across 12 countries) where they supply a narrow but critical sensing capability. This profile suggests a technology provider comfortable plugging into bigger teams, not an organisation that drives consortium assembly itself.
Their network spans 49 distinct partners across 12 countries, consistent with the pan-European ECSEL electronics and photonics ecosystem. No single-country dependency is visible — the reach is clearly European rather than purely Dutch.
What sets them apart
Few SMEs combine custom NIR and mid-IR photodetector know-how with active illumination design and system-level hyperspectral imaging under one roof. Their track record inside ECSEL places them in the serious electronic-components league, while the PHOOTONICS pivot proves they can carry that know-how into regulated medical device territory. For a consortium needing an imaging subsystem that works beyond the visible spectrum and must survive real-world clinical or industrial use, they are a credible specialist.
Highlights from their portfolio
- PHOOTONICSLongest and most recent project (2019-2024); marks their decisive move into hyperspectral medical devices for diabetic foot monitoring and is the richest source of evidence about their current capabilities.
- ASTONISHBridges their early sensor IP and their current health focus — Smart Optical Imaging and Sensing for Health sits exactly at the pivot point of their evolution.
- EXISTTheir earliest H2020 engagement under ECSEL-RIA, establishing the extended image sensing foundation their later work builds on.